Skip to main content
. 2022 Feb 22;58(3):412–422. doi: 10.23736/S1973-9087.22.07087-3

Table V. —Results of the shoulder joint active range of motions.

Active range of motions of shoulder hrESWT mrESWT prESWT P* η2 Post-hoc PC
Mean±SD Mean±SD Mean±SD
Flexion
AROM°
Baseline 118.25±18.02 132.42±19.12 130.77±18.47 0.118 0.11
After treatment 159.89±14.96 159.44±17.26 132.59±17.19 <0.001 0.39 1-3 (P=0.001)
2-3 (P=0.001)
Mean change
(95% CI)
41.64±20.94
(54.29; 28.98)
27.02±18.13
(37.97; 16.06)
1.82±13.80
(-10.16; 6.52)
<0.001 0.48 1-3 (p˂0.001)
2-3 (P=0.003)
Effect size P^ 1.99 P<0.001 1.49 P<0.001 0.13 P=0.643
Abduction
AROM°
Baseline 78.18±23.48 100.10±28.45 91.62±25.79 0.110 0.12
After treatment 124.13±32.42 139.14±37.14 99.68±22.49 0.010 0.23 2-3 (P=0.008)
Mean change (95% CI) 45.95±21.32
(58.83; 33.06)
39.04±18.99
(50.52; 27.56)
8.06±12.85
(15.83; 0.28)
<0.001 0.47 1-3 (P˂0.001)
2-3 (P˂0.001)
Effect size P^ 2.31 P<0.001 2.27 P<0.001 0.65 P=0.043
External rotation
AROM°
Baseline 26.75±16.26 39.84±18.4 32.33±11.26 0.114 0.11
After treatment 58.97±18.89 55.22±17.38 37.38±8.39 0.002 0.28 1-3 (P=0.003)
2-3 (P=0.016)
Mean change
(95% CI)
32.22±14.65
(41.07; 23.37)
15.38±9.65
(21.21; 9.55)
5.05±7.47
(9.56; 0.53)
<0.001 0.53 1-2 (P=0.001)
1-3 (P˂0.001)
Effect size P^ 2.22 P<0.001 1.60 P<0.001 0.72 P=0.031
Internal rotation
AROM
Baseline 36.40±18.38 58.00±21.87 43.46±15.58 0.025 0.62 1-2 (P=0.015)
After treatment 62.26±21.82 76.19±19.84 51.81±10.76 0.186 0.23
Mean change
(95% CI)
25.86±13.24
(17.45; 34.27)
18.19±14.63
(9.35; 27.03)
8.35±14.59
(-1.46; 18.15)
0.020 0.21 1-3 (P=0.015)
Effect size P^ 1.28 P<0.001 0.87 P=0.001 0.62 P=0.087

Data shown are mean±standard deviation, mean change, and 95% CI. Statistically significance: P˂0.005. Models Test: 1 (hrESWT); 2 (mrESWT); 3 (prESWT); 1-3 (hrESWT statistically different from prESWT); 2-3 (mrESWT statistically different from prESWT). hrESWT: High-energy radial extracorporeal shock wave therapy (0.25 mj/mm2); mrESWT: medium-energy radial extracorporeal shock wave therapy (0.12 mj/mm2); prESWT: placebo radial extracorporeal shock wave therapy (0.0 mj/mm2); 0: no difficulty in functionality; 100: worst difficulty requiring assistance; η2: partial eta squared (the norms for partial eta-squared [small: 0.01], [medium: 0.06]; [large: 0.14]); PC: pairwise comparison; AROM: active range of motion (° measured in degree). ^Significance level of paired sample t-test; *significance level of general linear mixed model test.